Life Technologies Corp (LIFE): Today's Featured Health Services Laggard

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Life Technologies ( LIFE) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.8%. By the end of trading, Life Technologies fell 83 cents (-1.8%) to $46.48 on average volume. Throughout the day, 2.1 million shares of Life Technologies exchanged hands as compared to its average daily volume of 1.5 million shares. The stock ranged in price between $46.34-$47.36 after having opened the day at $47.36 as compared to the previous trading day's close of $47.31. Other companies within the Health Services industry that declined today were: Bovie Medical Corporation ( BVX), down 10.8%, Arrhythmia Research Technology ( HRT), down 7.8%, ERBA Diagnostics ( ERB), down 5.9%, and BG Medicine ( BGMD), down 4.7%.

Life Technologies Corporation operates as a global life sciences company. Life Technologies has a market cap of $8.34 billion and is part of the health care sector. The company has a P/E ratio of 19.5, above the average health services industry P/E ratio of 19.3 and above the S&P 500 P/E ratio of 17.7. Shares are up 22% year to date as of the close of trading on Thursday. Currently there are nine analysts that rate Life Technologies a buy, no analysts rate it a sell, and seven rate it a hold.

TheStreet Ratings rates Life Technologies as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, attractive valuation levels and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the positive front, Thermogenesis Corporation ( KOOL), up 13.9%, Alliance HealthCare Services ( AIQ), up 10.4%, Celsion Corporation ( CLSN), up 9.1%, and Epocrates ( EPOC), up 8.3%, were all gainers within the health services industry with St Jude Medical ( STJ) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).